-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VNec47VQP6DqGg5sn9LGJywr1lJHDdULy/LYnuOu4SsFba0Vzj9oCALqqzQR9xeT L4HEz/MxsEnXdV9yxJF4TA== 0001209191-10-046618.txt : 20100916 0001209191-10-046618.hdr.sgml : 20100916 20100916171351 ACCESSION NUMBER: 0001209191-10-046618 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100914 FILED AS OF DATE: 20100916 DATE AS OF CHANGE: 20100916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 101076585 MAIL ADDRESS: STREET 1: 675 ALMANOR AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-09-14 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DRIVE REDWOOD CITY CA 94403 1 1 0 0 President and CEO Common Stock 2010-09-14 4 M 0 4000 2.88 A 292116 D Common Stock 2010-09-14 4 S 0 4000 15.1358 D 288116 D Common Stock 2010-09-15 4 M 0 3734 2.88 A 291850 D Common Stock 2010-09-15 4 S 0 3734 15.0636 D 288116 D Common Stock 12298 I By UBS for Benefit of Kimberly Popovits. Common Stock 10210 I Held by son. Employee Stock Option (right to buy) 2.88 2010-09-14 4 M 0 4000 0.00 D 2014-12-02 Common Stock 4000 49348 D Employee Stock Option (right to buy) 2.88 2010-09-15 4 M 0 3734 0.00 D 2014-12-02 Common Stock 3734 45614 D The number of shares originally covered by the exercised option was 66,666 options an exercise price per share of $3.00 per share. In connection with the issuer's initial public offering on October 4, 2005, a conditional dividend was issued which increased the number of shares covered by the option by 2,062 to 69,348, reducing the effective exercise price per share to $2.88. This sale of common stock was effected persuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2010. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $15.01 to $15.30. Represents weighted average sale price. Actual sale prices ranged from $15.00 to $15.17. The option becomes exercisable as to 25% of the shares on December 2, 2004, and becomes exercisable as to 1/48th of the shares each full month thereafter. Kimberly J. Popovits 2010-09-16 -----END PRIVACY-ENHANCED MESSAGE-----